Literature DB >> 31002842

TLR2 and TLR4 mediate an activation of adipose tissue renin-angiotensin system induced by uric acid.

Junxia Zhang1, Bo Diao2, Xue Lin3, Jinxiu Xu3, Feng Tang3.   

Abstract

Both hyperuricemia and adipose tissue renin-angiotensin system (RAS) are closely associated with multiple metabolic and cardiovascular diseases. We previously reported that uric acid could upregulate tissue RAS in adipocytes. In the present study, we aimed to reveal the involvement of toll-like receptors (TLRs) in uric acid-induced RAS activation in adipose tissue. A hyperuricemia rat model fed with a high-fructose diet and rat primary adipocytes were used in this study. Here, we inhibited TLR2 and TLR4 expression in adipose tissue and cultured adipocytes using small interfering RNA (siRNA). We found that high fructose-fed rats had hyperuricemia, higher body weight and greater adipose tissue content. We also found that hyperuricemia rats had raising blood pressure, higher expression levels of inflammatory cytokines and RAS components in adipose tissue, which could be prevented by TLR2/4-siRNA infection. In vitro study, uric acid caused a dose- and time-dependent increase in the mRNA expression of TLR2 and TLR4 in rat adipocytes. Uric acid could increase inflammatory cytokines and upregulate tissue RAS in rat adipocytes, which were both blocked with TLR2/4-siRNA infection. TNF-α and IL-6 could also result in an activation of tissue RAS expression in adipocytes. In conclusion, TLR2/4 mediated adipose inflammation plays a key role in RAS activation induced by uric acid in adipose tissue.
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Adipose tissue inflammation; Obesity; Renin-angiotensin system; Toll-like receptors; Uric acid

Year:  2019        PMID: 31002842     DOI: 10.1016/j.biochi.2019.04.013

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

1.  Association of Uric Acid-Lowering Therapy With Incident Chronic Kidney Disease.

Authors:  Waleed Hassan; Prabin Shrestha; Keiichi Sumida; Fridtjof Thomas; Patrick L Sweeney; Praveen K Potukuchi; Connie M Rhee; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization.

Authors:  Ting-Ting Feng; Xiao-Ying Yang; Shan-Shan Hao; Fen-Fen Sun; Ye Huang; Qi-Si Lin; Wei Pan
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

3.  CTRP3 protects against uric acid-induced endothelial injury by inhibiting inflammation and oxidase stress in rats.

Authors:  Junxia Zhang; Xue Lin; Jinxiu Xu; Feng Tang; Lupin Tan
Journal:  Exp Biol Med (Maywood)       Date:  2021-10-04

Review 4.  Uric Acid and Hypertension: Prognostic Role and Guide for Treatment.

Authors:  Federica Piani; Arrigo F G Cicero; Claudio Borghi
Journal:  J Clin Med       Date:  2021-01-24       Impact factor: 4.241

5.  Association of Uric Acid With Blood Pressure in Hypertension Between Treatment Group and Non-treatment Group.

Authors:  Ning Ding; Yong Long; Changluo Li; Liudang He; Yingjie Su
Journal:  Front Cardiovasc Med       Date:  2022-01-11

6.  The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway.

Authors:  Qian Nie; Miaomiao Liu; Zhimei Zhang; Xuemei Zhang; Chao Wang; Guangyao Song
Journal:  Mol Biol Rep       Date:  2021-10-30       Impact factor: 2.316

7.  Uric Acid Has Direct Proinflammatory Effects on Human Macrophages by Increasing Proinflammatory Mediators and Bacterial Phagocytosis Probably via URAT1.

Authors:  Camilo P Martínez-Reyes; Aarón N Manjarrez-Reyna; Lucia A Méndez-García; José A Aguayo-Guerrero; Beatriz Aguirre-Sierra; Rafael Villalobos-Molina; Yolanda López-Vidal; Karen Bobadilla; Galileo Escobedo
Journal:  Biomolecules       Date:  2020-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.